X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Colgate - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs COLGATE - Comparison Results

COLGATE 
   Change

Colgate is present in oral care, personal care and household care products with oral care contributing more than 90% to overall revenues. Colgate dominates in this core business with market shares of 54.5% in toothpastes and 38.2% in toothbrushes. Th... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES COLGATE AMAR REMEDIES/
COLGATE
 
P/E (TTM) x -0.5 50.3 - View Chart
P/BV x 0.1 22.8 0.3% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 AMAR REMEDIES   COLGATE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
COLGATE
Mar-17
AMAR REMEDIES/
COLGATE
5-Yr Chart
Click to enlarge
High Rs1641,033 15.9%   
Low Rs86788 10.9%   
Sales per share (Unadj.) Rs261.6146.4 178.7%  
Earnings per share (Unadj.) Rs17.421.2 81.9%  
Cash flow per share (Unadj.) Rs22.326.1 85.3%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs100.746.8 215.1%  
Shares outstanding (eoy) m26.16271.99 9.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.56.2 7.7%   
Avg P/E ratio x7.242.9 16.8%  
P/CF ratio (eoy) x5.634.8 16.1%  
Price / Book Value ratio x1.219.4 6.4%  
Dividend payout %047.1 0.0%   
Avg Mkt Cap Rs m3,270247,579 1.3%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m1632,885 5.6%   
Avg. sales/employee Rs ThNM16,494.7-  
Avg. wages/employee Rs ThNM1,195.1-  
Avg. net profit/employee Rs ThNM2,392.0-  
INCOME DATA
Net Sales Rs m6,84439,818 17.2%  
Other income Rs m21398 5.3%   
Total revenues Rs m6,86540,216 17.1%   
Gross profit Rs m1,1319,449 12.0%  
Depreciation Rs m1281,332 9.6%   
Interest Rs m3980-   
Profit before tax Rs m6268,514 7.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1212,740 4.4%   
Profit after tax Rs m4555,774 7.9%  
Gross profit margin %16.523.7 69.6%  
Effective tax rate %19.332.2 60.1%   
Net profit margin %6.614.5 45.8%  
BALANCE SHEET DATA
Current assets Rs m4,9048,556 57.3%   
Current liabilities Rs m3,58110,496 34.1%   
Net working cap to sales %19.3-4.9 -396.8%  
Current ratio x1.40.8 168.0%  
Inventory Days Days12427 463.4%  
Debtors Days Days10012 841.1%  
Net fixed assets Rs m1,68912,747 13.3%   
Share capital Rs m262272 96.3%   
"Free" reserves Rs m2,35812,466 18.9%   
Net worth Rs m2,63512,738 20.7%   
Long term debt Rs m5070-   
Total assets Rs m6,86223,234 29.5%  
Interest coverage x2.6NM-  
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.7 58.2%   
Return on assets %12.424.9 50.0%  
Return on equity %17.345.3 38.1%  
Return on capital %31.066.8 46.4%  
Exports to sales %4.03.5 113.2%   
Imports to sales %00-   
Exports (fob) Rs m2731,403 19.5%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2731,607 17.0%   
Fx outflow Rs m20-   
Net fx Rs m2711,607 16.9%   
CASH FLOW
From Operations Rs m-3136,880 -4.5%  
From Investments Rs m-489-3,422 14.3%  
From Financial Activity Rs m769-3,405 -22.6%  
Net Cashflow Rs m-3353 -61.1%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 51.0 -  
Indian inst/Mut Fund % 9.2 7.0 131.4%  
FIIs % 0.0 20.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 22.1 295.5%  
Shareholders   13,061 131,569 9.9%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ CONSUMER  ARCHIES LTD  RELAXO FOOTWEARS  BAJAJ CORP  MARICO LTD  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS